HUMAN PAPILLOMAVIRUS VACCINATION: PAST, PRESENT AND FUTURE

dc.contributor.authorAimagambetova, Gulzhanat
dc.contributor.authorAzizan, Azliyati
dc.date.accessioned2022-11-23T10:22:49Z
dc.date.available2022-11-23T10:22:49Z
dc.date.issued2022-08-26
dc.description.abstractThe link between human papillomavirus (HPV) infection and different diseases has been well-established since more than four decades ago [1,2]. Moreover, high-risk HPV types were confirmed as causative agents for a variety of malignant conditions, including oropharyngeal, anogenital, and cervical cancersen_US
dc.identifier.citationAimagambetova, G., & Azizan, A. (2022). Human Papillomavirus Vaccination: Past, Present and Future. Vaccines, 10(9), 1398. https://doi.org/10.3390/vaccines10091398en_US
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/6822
dc.language.isoenen_US
dc.publisherVaccinesen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjecthuman papillomavirusen_US
dc.subjectcausative agentsen_US
dc.subjectoropharyngealen_US
dc.subjectanogenitalen_US
dc.subjectcervical cancersen_US
dc.titleHUMAN PAPILLOMAVIRUS VACCINATION: PAST, PRESENT AND FUTUREen_US
dc.typeArticleen_US
workflow.import.sourcescience

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fmats-08-655207.pdf
Size:
1.06 MB
Format:
Adobe Portable Document Format
Description:
Article

Collections